Needle Anxiety: A Barrier to Patient Adherence and Positive Health Outcomes

The social stigma around needle use and inherent discomfort around needle handling can create barriers to adoption and sustained adherence to a prescribed treatment plan.

Read More

Fear of Needles May Chip Away at Vaccination Rates

The reasons people may skip vaccines such as the flu shot are many. They can include apathy or being too busy. They can include people believing that they won’t get sick or fearing vaccines. But recent research suggests another reason some may skip shots: fear of needles. And it’s a fear that may be preventable.

Read More

The Negative Impact of Needle Anxiety on Patient Health

Numerous patients around the world experience terrible anxiety when faced with the prospect of a needle-based injection. The distress can be so overwhelming that patients sometimes skip doses or simply choose to forego treatment entirely.

Read More

Combating Medication Non-Adherence with Leading-Edge Technology

Medicine only works when taken consistently, making medication adherence essential to achieving positive treatment outcomes. It is estimated that 190 million Americans are affected by one or more chronic conditions, most of which can be managed via medication. Non-adherence is a loss for everyone.

Read More

Biologics: Advanced Drugs that Deserve an Advanced Delivery Technology

Compared to conventional pharmaceutical drugs, biologics feature robust therapeutic efficacy, high selectivity, and limited side effects. However, there are marked limitations for the delivery of biologic drugs.

Read More

Planning Your Feasibility Study in Three Easy Steps

Portal’s Needle-Free Drug Delivery System is now available for clinical testing, human factor evaluation, and commercial planning.

Read More

The End of Needles: A Personal Win for Patients

Patients with chronic conditions who must receive frequent, sometimes even daily, injections are all too familiar with the sting and the inherent anxiety of handling needles. Portal’s innovative needle-free platform is changing the paradigm of care.

Read More

Takeda and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery Device

Portal Instruments and Takeda announced a collaboration to develop and commercialize Portal’s game changing needle-free drug delivery platform for potential use with Takeda’s investigational or approved biologic medicines.

Read More

A Letter From the CEO

Today we announced a groundbreaking partnership with Takeda. This is a significant milestone for Portal as it begins to validate our business model. I am thrilled about this achievement and would like to thank the whole team that has worked tirelessly to make this happen.

Read More

Boston Voyager Interviews Portal Instruments’ CEO Patrick Anquetil

Patrick Anquetil, CEO of Portal Instruments, was recently featured in Boston Voyager, an online magazine that focuses on local trends, start-ups and local businesses.

Read More